Aldeyra Therapeutics
ALDX
$3.93
Share price
-0.25%
Change (1 day)
-58.76%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Total debt
Total debt on the balance sheet as of December 2023 : $15.65 M
According to Aldeyra Therapeutics 's latest financial reports the company's total debt is $15.65 M. A company’s total debt is the sum of all current and non-current debts.
Aldeyra Therapeutics - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $15.65 M | -2.65% |
| 2022-12-31 | $16.08 M | 1.42% |
| 2021-12-31 | $15.85 M | 3.46% |
| 2020-12-31 | $15.32 M | 3.88% |
| 2019-12-31 | $14.75 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $1.33 M | 1.55% |
| 2016-12-31 | $1.31 M | 2.12% |
| 2015-12-31 | $1.28 M | 2.86% |
| 2014-12-31 | $1.25 M | -1.51% |
| 2013-12-31 | $1.27 M | 193.86% |
| 2012-12-31 | $0.43 M | -80.32% |
| 2011-12-31 | $2.2 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $2.70 B | 17,162.76% | 🇺🇸 USA |